Sunday, October 06, 2024 12:19:04 AM
Dstock, I don't know that 2 gm. is all that's needed to create a full batch of the vaccine, but if true, shouldn't it be possible to remove that much without surgery.
This would bring up the question, would treatment be equally effective, or even better, with a 2 gm sample of the tumor, and the right additional therapeutics added, or is it best to remove all the tumor that it's possible to remove.
Common logic might say take it all, but recovery from massive surgery might be tougher on the patient than use of a vaccine and other therapeutics that truly can eliminate the tumor from within.
I cannot say we're there, but over time I believe it's the direction we will be taking as we discover what can get the job done in that manner. Hopefully our vaccine will continue to be a part of the process in many forms of cancer.
Gary
This would bring up the question, would treatment be equally effective, or even better, with a 2 gm sample of the tumor, and the right additional therapeutics added, or is it best to remove all the tumor that it's possible to remove.
Common logic might say take it all, but recovery from massive surgery might be tougher on the patient than use of a vaccine and other therapeutics that truly can eliminate the tumor from within.
I cannot say we're there, but over time I believe it's the direction we will be taking as we discover what can get the job done in that manner. Hopefully our vaccine will continue to be a part of the process in many forms of cancer.
Gary
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
